Frontage takes your lead candidate to first in human

Our preclinical or clinical services provides a comprehensive suite of services including DMPK, preclinical safety/toxicology, and clinical trial services with strategic and regulatory support to effectively bring new lead candidates through the IND stage to Phase II. 

Drug Metabolism & Pharmacokinetics (DMPK)

Proven techniques and best-in-class approaches

Safety Assessment & Toxicology

Streamlining your development process

Clinical Services

Advancing your investigative compound to a drug candidate

As your drug development partner, we offer scientific and regulatory strategic consulting, and conduct all aspects of the required testing leading to preparation and submission of an IND application, FDA interactions, and Phase 1 clinical studies.

Integrated Services to Support your Entire IND Enabling Program

In partnership with our sponsors, Frontage made the commitment to provide a single source of drug development services as a complete package to support the efficient and cost-effective development of new drugs. 

Our approach supports the advancement of your drug candidate to FIH studies. Our overall package includes: 

• Synthesis and Characterization of API 
• Drug Metabolism and Pharmacokinetics (DMPK) 
• Safety and Toxicology
• Chemistry, Manufacturing, and Controls (CMC) 
• First-in-Human (FIH) Studies 
• Dedicated Project Management 
• Preparation of IND submission-ready documents